APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arginine (Cas 74-79-3)

Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.

Selected research

Market Outlook & Growth Opportunities

Global Arginine (Cas 74-79-3) Market Outlook and Growth Opportunities 2026

26 December 2025192 pages

Choose your research edition.

Industry ResearchArginine (Cas 74-79-3) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Arginine (Cas 74-79-3) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Arginine (Cas 74-79-3) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arginine (Cas 74-79-3) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Arginine (Cas 74-79-3) Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.

Europe is the largest region of Arginine (Cas 74-79-3), with a market share about 30%. It was followed by North America with 25%. Ajinomoto group, KYOWA, Daesang, Jingjing, Jinghai Amino Acid and Jiahe Biotech are the leaders of of industry, and they had about 50% combined market share.

This report provides an overview of the global Arginine (Cas 74-79-3) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Arginine (Cas 74-79-3) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Arginine (Cas 74-79-3) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Arginine (Cas 74-79-3) market size, projected growth trends, production technologies, key applications, and end-use industries.

Arginine (Cas 74-79-3) Segment by Company

Ajinomoto Group

KYOWA

Daesang

CJ

JingJing

Jinghai Amino Acid

Jiahe Biotech

SHINE STAR

Xingyu Technology

Longteng Biotech

Arginine (Cas 74-79-3) Segment by Type

Food Grade

Pharma Grade

Others

Arginine (Cas 74-79-3) Segment by Application

Supplements & Nutrition

Pharmaceuticals

Cosmetics

Others

Arginine (Cas 74-79-3) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Arginine (Cas 74-79-3) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Arginine (Cas 74-79-3) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Arginine (Cas 74-79-3) significant trends, drivers, influence factors in global and regions.

6. To analyze Arginine (Cas 74-79-3) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arginine (Cas 74-79-3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arginine (Cas 74-79-3) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arginine (Cas 74-79-3).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Arginine (Cas 74-79-3) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Arginine (Cas 74-79-3) industry.

Chapter 3: Detailed analysis of Arginine (Cas 74-79-3) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Arginine (Cas 74-79-3) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Arginine (Cas 74-79-3) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Arginine (Cas 74-79-3) Industry Trends Table 2. Arginine (Cas 74-79-3) Industry Drivers Table 3. Arginine (Cas 74-79-3) Industry Opportunities and Challenges Table 4. Arginine (Cas 74-79-3) Industry Restraints Table 5. Global Arginine (Cas 74-79-3) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Arginine (Cas 74-79-3) Revenue Share by Company (2021-2026) Table 7. Global Arginine (Cas 74-79-3) Sales Volume by Company (t) & (2021-2026) Table 8. Global Arginine (Cas 74-79-3) Sales Volume Share by Company (2021-2026) Table 9. Global Arginine (Cas 74-79-3) Average Price (USD/kg) of Company (2021-2026) Table 10. Global Arginine (Cas 74-79-3) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Arginine (Cas 74-79-3) Key Company Manufacturing Base & Headquarters Table 12. Global Arginine (Cas 74-79-3) Company, Product Type & Application Table 13. Global Arginine (Cas 74-79-3) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Arginine (Cas 74-79-3) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Food Grade Table 18. Significant Companies of Pharma Grade Table 19. Significant Companies of Others Table 20. Global Arginine (Cas 74-79-3) Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Arginine (Cas 74-79-3) Sales Volume by Type (2021-2026) & (t) Table 22. Global Arginine (Cas 74-79-3) Sales Volume by Type (2027-2032) & (t) Table 23. Global Arginine (Cas 74-79-3) Sales Volume Share by Type (2021-2026) Table 24. Global Arginine (Cas 74-79-3) Sales Volume Share by Type (2027-2032) Table 25. Global Arginine (Cas 74-79-3) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Arginine (Cas 74-79-3) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Arginine (Cas 74-79-3) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Arginine (Cas 74-79-3) Sales Value Share by Type (2021-2026) Table 29. Global Arginine (Cas 74-79-3) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Supplements & Nutrition Table 31. Significant Companies of Pharmaceuticals Table 32. Significant Companies of Cosmetics Table 33. Significant Companies of Others Table 34. Global Arginine (Cas 74-79-3) Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Arginine (Cas 74-79-3) Sales Volume by Application (2021-2026) & (t) Table 36. Global Arginine (Cas 74-79-3) Sales Volume by Application (2027-2032) & (t) Table 37. Global Arginine (Cas 74-79-3) Sales Volume Share by Application (2021-2026) Table 38. Global Arginine (Cas 74-79-3) Sales Volume Share by Application (2027-2032) Table 39. Global Arginine (Cas 74-79-3) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Arginine (Cas 74-79-3) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Arginine (Cas 74-79-3) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Arginine (Cas 74-79-3) Sales Value Share by Application (2021-2026) Table 43. Global Arginine (Cas 74-79-3) Sales Value Share by Application (2027-2032) Table 44. Global Arginine (Cas 74-79-3) Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Arginine (Cas 74-79-3) Sales by Region (2021-2026) & (t) Table 46. Global Arginine (Cas 74-79-3) Sales Market Share by Region (2021-2026) Table 47. Global Arginine (Cas 74-79-3) Sales by Region (2027-2032) & (t) Table 48. Global Arginine (Cas 74-79-3) Sales Market Share by Region (2027-2032) Table 49. Global Arginine (Cas 74-79-3) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Arginine (Cas 74-79-3) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Arginine (Cas 74-79-3) Sales Value Share by Region (2021-2026) Table 52. Global Arginine (Cas 74-79-3) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Arginine (Cas 74-79-3) Sales Value Share by Region (2027-2032) Table 54. Global Arginine (Cas 74-79-3) Market Average Price (USD/kg) by Region (2021-2026) Table 55. Global Arginine (Cas 74-79-3) Market Average Price (USD/kg) by Region (2027-2032) Table 56. Global Arginine (Cas 74-79-3) Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Arginine (Cas 74-79-3) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Arginine (Cas 74-79-3) Sales by Country (2021-2026) & (t) Table 59. Global Arginine (Cas 74-79-3) Sales Market Share by Country (2021-2026) Table 60. Global Arginine (Cas 74-79-3) Sales by Country (2027-2032) & (t) Table 61. Global Arginine (Cas 74-79-3) Sales Market Share by Country (2027-2032) Table 62. Global Arginine (Cas 74-79-3) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Arginine (Cas 74-79-3) Sales Value Market Share by Country (2021-2026) Table 64. Global Arginine (Cas 74-79-3) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Arginine (Cas 74-79-3) Sales Value Market Share by Country (2027-2032) Table 66. Ajinomoto Group Company Information Table 67. Ajinomoto Group Business Overview Table 68. Ajinomoto Group Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 69. Ajinomoto Group Arginine (Cas 74-79-3) Product Portfolio Table 70. Ajinomoto Group Recent Development Table 71. KYOWA Company Information Table 72. KYOWA Business Overview Table 73. KYOWA Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. KYOWA Arginine (Cas 74-79-3) Product Portfolio Table 75. KYOWA Recent Development Table 76. Daesang Company Information Table 77. Daesang Business Overview Table 78. Daesang Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Daesang Arginine (Cas 74-79-3) Product Portfolio Table 80. Daesang Recent Development Table 81. CJ Company Information Table 82. CJ Business Overview Table 83. CJ Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. CJ Arginine (Cas 74-79-3) Product Portfolio Table 85. CJ Recent Development Table 86. JingJing Company Information Table 87. JingJing Business Overview Table 88. JingJing Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. JingJing Arginine (Cas 74-79-3) Product Portfolio Table 90. JingJing Recent Development Table 91. Jinghai Amino Acid Company Information Table 92. Jinghai Amino Acid Business Overview Table 93. Jinghai Amino Acid Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Jinghai Amino Acid Arginine (Cas 74-79-3) Product Portfolio Table 95. Jinghai Amino Acid Recent Development Table 96. Jiahe Biotech Company Information Table 97. Jiahe Biotech Business Overview Table 98. Jiahe Biotech Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Jiahe Biotech Arginine (Cas 74-79-3) Product Portfolio Table 100. Jiahe Biotech Recent Development Table 101. SHINE STAR Company Information Table 102. SHINE STAR Business Overview Table 103. SHINE STAR Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. SHINE STAR Arginine (Cas 74-79-3) Product Portfolio Table 105. SHINE STAR Recent Development Table 106. Xingyu Technology Company Information Table 107. Xingyu Technology Business Overview Table 108. Xingyu Technology Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. Xingyu Technology Arginine (Cas 74-79-3) Product Portfolio Table 110. Xingyu Technology Recent Development Table 111. Longteng Biotech Company Information Table 112. Longteng Biotech Business Overview Table 113. Longteng Biotech Arginine (Cas 74-79-3) Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Longteng Biotech Arginine (Cas 74-79-3) Product Portfolio Table 115. Longteng Biotech Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Arginine (Cas 74-79-3) Distributors List Table 119. Arginine (Cas 74-79-3) Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Arginine (Cas 74-79-3) Product Image Figure 2. Global Arginine (Cas 74-79-3) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arginine (Cas 74-79-3) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Arginine (Cas 74-79-3) Sales (2021-2032) & (t) Figure 5. Global Arginine (Cas 74-79-3) Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Arginine (Cas 74-79-3) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Food Grade Image Figure 10. Pharma Grade Image Figure 11. Others Image Figure 12. Global Arginine (Cas 74-79-3) Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Arginine (Cas 74-79-3) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Arginine (Cas 74-79-3) Sales Volume Share by Type (2021-2032) Figure 15. Global Arginine (Cas 74-79-3) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Arginine (Cas 74-79-3) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Arginine (Cas 74-79-3) Sales Value Share by Type (2021-2032) Figure 18. Supplements & Nutrition Image Figure 19. Pharmaceuticals Image Figure 20. Cosmetics Image Figure 21. Others Image Figure 22. Global Arginine (Cas 74-79-3) Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Arginine (Cas 74-79-3) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Arginine (Cas 74-79-3) Sales Volume Share by Application (2021-2032) Figure 25. Global Arginine (Cas 74-79-3) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Arginine (Cas 74-79-3) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Arginine (Cas 74-79-3) Sales Value Share by Application (2021-2032) Figure 28. Global Arginine (Cas 74-79-3) Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Arginine (Cas 74-79-3) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Arginine (Cas 74-79-3) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Arginine (Cas 74-79-3) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Arginine (Cas 74-79-3) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Arginine (Cas 74-79-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Arginine (Cas 74-79-3) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Arginine (Cas 74-79-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Arginine (Cas 74-79-3) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Arginine (Cas 74-79-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Arginine (Cas 74-79-3) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Arginine (Cas 74-79-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Arginine (Cas 74-79-3) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Arginine (Cas 74-79-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Arginine (Cas 74-79-3) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Arginine (Cas 74-79-3) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade
  • Pharma Grade
  • Others
Applications
  • Supplements & Nutrition
  • Pharmaceuticals
  • Cosmetics
  • Others
Companies covered
  • Ajinomoto Group
  • KYOWA
  • Daesang
  • CJ
  • JingJing
  • Jinghai Amino Acid
  • Jiahe Biotech
  • SHINE STAR
  • Xingyu Technology
  • Longteng Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Arginine (Cas 74-79-3) Sales Value (2021-2032)
  4. 1.2.2 Global Arginine (Cas 74-79-3) Sales Volume (2021-2032)
  5. 1.2.3 Global Arginine (Cas 74-79-3) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Arginine (Cas 74-79-3) Market Dynamics
  1. 2.1 Arginine (Cas 74-79-3) Industry Trends
  2. 2.2 Arginine (Cas 74-79-3) Industry Drivers
  3. 2.3 Arginine (Cas 74-79-3) Industry Opportunities and Challenges
  4. 2.4 Arginine (Cas 74-79-3) Industry Restraints
3 Arginine (Cas 74-79-3) Market by Company
  1. 3.1 Global Arginine (Cas 74-79-3) Company Revenue Ranking in 2025
  2. 3.2 Global Arginine (Cas 74-79-3) Revenue by Company (2021-2026)
  3. 3.3 Global Arginine (Cas 74-79-3) Sales Volume by Company (2021-2026)
  4. 3.4 Global Arginine (Cas 74-79-3) Average Price by Company (2021-2026)
  5. 3.5 Global Arginine (Cas 74-79-3) Company Ranking (2024-2026)
  6. 3.6 Global Arginine (Cas 74-79-3) Company Manufacturing Base and Headquarters
  7. 3.7 Global Arginine (Cas 74-79-3) Company Product Type and Application
  8. 3.8 Global Arginine (Cas 74-79-3) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Arginine (Cas 74-79-3) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Arginine (Cas 74-79-3) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Arginine (Cas 74-79-3) Market by Type
  1. 4.1 Arginine (Cas 74-79-3) Type Introduction
  2. 4.1.1 Food Grade
  3. 4.1.2 Pharma Grade
  4. 4.1.3 Others
  5. 4.2 Global Arginine (Cas 74-79-3) Sales Volume by Type
  6. 4.2.1 Global Arginine (Cas 74-79-3) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Arginine (Cas 74-79-3) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Arginine (Cas 74-79-3) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Arginine (Cas 74-79-3) Sales Value by Type
  10. 4.3.1 Global Arginine (Cas 74-79-3) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Arginine (Cas 74-79-3) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Arginine (Cas 74-79-3) Sales Value Share by Type (2021-2032)
5 Arginine (Cas 74-79-3) Market by Application
  1. 5.1 Arginine (Cas 74-79-3) Application Introduction
  2. 5.1.1 Supplements & Nutrition
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Cosmetics
  5. 5.1.4 Others
  6. 5.2 Global Arginine (Cas 74-79-3) Sales Volume by Application
  7. 5.2.1 Global Arginine (Cas 74-79-3) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Arginine (Cas 74-79-3) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Arginine (Cas 74-79-3) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Arginine (Cas 74-79-3) Sales Value by Application
  11. 5.3.1 Global Arginine (Cas 74-79-3) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Arginine (Cas 74-79-3) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Arginine (Cas 74-79-3) Sales Value Share by Application (2021-2032)
6 Arginine (Cas 74-79-3) Regional Sales and Value Analysis
  1. 6.1 Global Arginine (Cas 74-79-3) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Arginine (Cas 74-79-3) Sales by Region (2021-2032)
  3. 6.2.1 Global Arginine (Cas 74-79-3) Sales by Region: 2021-2026
  4. 6.2.2 Global Arginine (Cas 74-79-3) Sales by Region (2027-2032)
  5. 6.3 Global Arginine (Cas 74-79-3) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Arginine (Cas 74-79-3) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Arginine (Cas 74-79-3) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Arginine (Cas 74-79-3) Sales Value by Region (2027-2032)
  9. 6.5 Global Arginine (Cas 74-79-3) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Arginine (Cas 74-79-3) Sales Value (2021-2032)
  12. 6.6.2 North America Arginine (Cas 74-79-3) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Arginine (Cas 74-79-3) Sales Value (2021-2032)
  15. 6.7.2 Europe Arginine (Cas 74-79-3) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Arginine (Cas 74-79-3) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Arginine (Cas 74-79-3) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Arginine (Cas 74-79-3) Sales Value (2021-2032)
  21. 6.9.2 South America Arginine (Cas 74-79-3) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Arginine (Cas 74-79-3) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Arginine (Cas 74-79-3) Sales Value Share by Country, 2025 VS 2032
7 Arginine (Cas 74-79-3) Country-level Sales and Value Analysis
  1. 7.1 Global Arginine (Cas 74-79-3) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Arginine (Cas 74-79-3) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Arginine (Cas 74-79-3) Sales by Country (2021-2032)
  4. 7.3.1 Global Arginine (Cas 74-79-3) Sales by Country (2021-2026)
  5. 7.3.2 Global Arginine (Cas 74-79-3) Sales by Country (2027-2032)
  6. 7.4 Global Arginine (Cas 74-79-3) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Arginine (Cas 74-79-3) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Arginine (Cas 74-79-3) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Arginine (Cas 74-79-3) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Arginine (Cas 74-79-3) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Arginine (Cas 74-79-3) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ajinomoto Group
  2. 8.1.1 Ajinomoto Group Company Information
  3. 8.1.2 Ajinomoto Group Business Overview
  4. 8.1.3 Ajinomoto Group Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ajinomoto Group Arginine (Cas 74-79-3) Product Portfolio
  6. 8.1.5 Ajinomoto Group Recent Developments
  7. 8.2 KYOWA
  8. 8.2.1 KYOWA Company Information
  9. 8.2.2 KYOWA Business Overview
  10. 8.2.3 KYOWA Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 KYOWA Arginine (Cas 74-79-3) Product Portfolio
  12. 8.2.5 KYOWA Recent Developments
  13. 8.3 Daesang
  14. 8.3.1 Daesang Company Information
  15. 8.3.2 Daesang Business Overview
  16. 8.3.3 Daesang Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Daesang Arginine (Cas 74-79-3) Product Portfolio
  18. 8.3.5 Daesang Recent Developments
  19. 8.4 CJ
  20. 8.4.1 CJ Company Information
  21. 8.4.2 CJ Business Overview
  22. 8.4.3 CJ Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CJ Arginine (Cas 74-79-3) Product Portfolio
  24. 8.4.5 CJ Recent Developments
  25. 8.5 JingJing
  26. 8.5.1 JingJing Company Information
  27. 8.5.2 JingJing Business Overview
  28. 8.5.3 JingJing Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 JingJing Arginine (Cas 74-79-3) Product Portfolio
  30. 8.5.5 JingJing Recent Developments
  31. 8.6 Jinghai Amino Acid
  32. 8.6.1 Jinghai Amino Acid Company Information
  33. 8.6.2 Jinghai Amino Acid Business Overview
  34. 8.6.3 Jinghai Amino Acid Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jinghai Amino Acid Arginine (Cas 74-79-3) Product Portfolio
  36. 8.6.5 Jinghai Amino Acid Recent Developments
  37. 8.7 Jiahe Biotech
  38. 8.7.1 Jiahe Biotech Company Information
  39. 8.7.2 Jiahe Biotech Business Overview
  40. 8.7.3 Jiahe Biotech Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiahe Biotech Arginine (Cas 74-79-3) Product Portfolio
  42. 8.7.5 Jiahe Biotech Recent Developments
  43. 8.8 SHINE STAR
  44. 8.8.1 SHINE STAR Company Information
  45. 8.8.2 SHINE STAR Business Overview
  46. 8.8.3 SHINE STAR Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 SHINE STAR Arginine (Cas 74-79-3) Product Portfolio
  48. 8.8.5 SHINE STAR Recent Developments
  49. 8.9 Xingyu Technology
  50. 8.9.1 Xingyu Technology Company Information
  51. 8.9.2 Xingyu Technology Business Overview
  52. 8.9.3 Xingyu Technology Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Xingyu Technology Arginine (Cas 74-79-3) Product Portfolio
  54. 8.9.5 Xingyu Technology Recent Developments
  55. 8.10 Longteng Biotech
  56. 8.10.1 Longteng Biotech Company Information
  57. 8.10.2 Longteng Biotech Business Overview
  58. 8.10.3 Longteng Biotech Arginine (Cas 74-79-3) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Longteng Biotech Arginine (Cas 74-79-3) Product Portfolio
  60. 8.10.5 Longteng Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Arginine (Cas 74-79-3) Value Chain Analysis
  2. 9.1.1 Arginine (Cas 74-79-3) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Arginine (Cas 74-79-3) Sales Mode & Process
  6. 9.2 Arginine (Cas 74-79-3) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Arginine (Cas 74-79-3) Distributors
  9. 9.2.3 Arginine (Cas 74-79-3) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst